284 filings
Page 7 of 15
20-F
2018 FY
AFMD
Affimed N.V.
Annual report (foreign)
27 Mar 19
7:01am
SC 13G/A
AFMD
Affimed N.V.
14 Feb 19
Affimed N.V.
9:07am
SC 13G/A
AFMD
Affimed N.V.
12 Feb 19
Affimed N.V.
9:36am
SC 13G/A
AFMD
Affimed N.V.
25 Jan 19
Affimed N.V.
11:31am
SC 13G/A
AFMD
Affimed N.V.
15 Jan 19
Affimed N.V.
4:33pm
6-K
AFMD
Affimed N.V.
7 Jan 19
Actualizing the Untapped Potential of the Innate Immune System Affimed’s Approach to Advancing Immuno - oncology January 2019
7:01am
424B5
AFMD
Affimed N.V.
8 Nov 18
Prospectus supplement for primary offering
4:31pm
EFFECT
AFMD
Affimed N.V.
8 Nov 18
Notice of effectiveness
12:15am
6-K
AFMD
Affimed N.V.
7 Nov 18
Condensed Consolidated Financial Statements
7:31am
UPLOAD
AFMD
Affimed N.V.
6 Nov 18
Letter from SEC
12:00am
CORRESP
AFMD
Affimed N.V.
5 Nov 18
Correspondence with SEC
12:00am
6-K
AFMD
Affimed N.V.
1 Nov 18
Affimed Announces Oral Presentation and Five Poster Presentations at the 2018 American Society of Hematology Annual Meeting
9:20am
F-3
AFMD
Affimed N.V.
22 Oct 18
Shelf registration (foreign)
4:32pm
6-K/A
AFMD
Affimed N.V.
16 Oct 18
Current report (foreign) (amended)
4:30pm
6-K
AFMD
Affimed N.V.
9 Oct 18
Affimed Places AFM11 (CD19/CD3-Targeting T cell Engager) Phase 1 Program on Clinical Hold
6:05am
SC 13D/A
SGR Sagittarius Holding AG
3 Oct 18
Affimed N.V.
4:12pm
SC 13D/A
SGR Sagittarius Holding AG
26 Sep 18
Affimed N.V.
12:00am
SC 13D/A
SGR Sagittarius Holding AG
19 Sep 18
Affimed N.V.
10:44am
CT ORDER
AFMD
Affimed N.V.
17 Sep 18
Confidential treatment order
12:00am
6-K
AFMD
Affimed N.V.
27 Aug 18
Current report (foreign)
12:00am